SHOULD ALL PREGNANT WOMEN BE TESTED FOR THEIR PLATELET PLA (Zw, HPA‐1) PHENOTYPE?
- 1 January 1994
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 86 (1) , 1-5
- https://doi.org/10.1111/j.1365-2141.1994.tb03244.x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2and PLA2/PLA2genotypesBritish Journal of Haematology, 1992
- Structural and functional characterization of major platelet membrane components derived by limited proteolysis of glycoprotein IIIaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Antenatal Treatment of Neonatal Alloimmune ThrombocytopeniaNew England Journal of Medicine, 1988
- Incidentally Detected Thrombocytopenia in Healthy Mothers and Their InfantsNew England Journal of Medicine, 1988
- Alloimmunization against the platelet-specific Zwa antigen, resulting in neonatal alloimmune thrombocytopenia or posttransfusion purpura, is associated with the supertypic DRw52 antigen including DR3 and DRw6Human Immunology, 1986
- In Utero Cerebral Hemorrhage in Alloimmune ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1986
- Studies on the nature of the human platelet alloantigen, Pla1 localization to a 17,000-dalton polypeptideMolecular Immunology, 1985
- HLA antigens and maternal antibodies in allo‐immune neonatal thrombocytopeniaTissue Antigens, 1983
- HLA‐B8 antigen and anti‐PLA1 allo‐immunizationTissue Antigens, 1981
- Intracranial hemorrhage in utero as a complication ofisoimmune thrombocytopeniaThe Journal of Pediatrics, 1979